Kappa Bioscience

Kappa Bioscience AS, founded in 2006 and based in Oslo, Norway, specializes in the development and production of vitamin K2, specifically menaquinone-7 (MK-7), marketed under the K2VITAL brand. The company is recognized as a pioneer in synthesizing this biologically active form of vitamin K2, which enhances its marketability and accessibility in the food supplement and fortified food sectors. Kappa Bioscience also employs innovative techniques such as the DELTA microencapsulation process, which ensures the stability of vitamin K2 in mineral formulations. Its product offerings include K2VITAL, along with various formulations suitable for dietary supplements, fortified foods, and nutritional products aimed at improving bone, joint, and cardiovascular health. The company distributes its products through a network of global distributors, particularly in Norway and the United States, ensuring a secure supply chain and maintaining high standards of ingredient purity.